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nvasive physiologic indices for the assessment of
intermediate coronary lesions have become the
standard of care as per guideline recommendations.
Hyperemic fractional flow reserve (FFR) is the established physiologic index based on favorable long-term
prognostic data.1–4 Recently, nonhyperemic diastolic
pressure ratios (NHPRs) such as instantaneous wavefree ratio (iFR) have emerged as resting physiologic
indices that perform comparably to FFR for clinical decision making.5–8 When the FFR and NHPRs measurements are concordant (NHPRs+/FFR+ or NHPRs−/
FFR−), the decision to revascularize is straightforward.
However, when the measurements of FFR and NHPR
are discordant (NHPRs+/FFR− or NHPRs−/FFR+) (as in
≈20% of cases),9 the operator is left with a dilemma, as
the clinical outcomes of discordant lesions are unclear.

See Article by Lee et al.
Several randomized clinical trials have compared
FFR versus angiography and FFR versus iFR for longterm outcomes.1–4,7,8 The results of the FAME (Fractional
Flow Reserve Versus Angiography for Multivessel
Evaluation), FAME-2, and DEFER (Deferral Versus
Performance of Percutaneous Coronary Intervention
of Functionally Nonsignificant Coronary Stenosis) trials demonstrated the clinical benefit of using FFR to

guide revascularization decisions and the safety of
deferring revascularization when FFR is negative in intermediate coronary stenoses.1–4 The DEFINE-FLAIR
trial (Functional Lesion Assessment of Intermediate
Stenosis to Guide Revascularization) and the iFR-SWEDEHEART trial (Instantaneous Wave-Free Ratio Versus
Fractional Flow Reserve in Patients With Stable Angina
Pectoris or Acute Coronary Syndrome) demonstrated
that iFR was noninferior to FFR in clinical outcomes
in lesions deferred for revascularization.7,8 Based on
these outcome studies, the 2018 European Society of
Cardiology guidelines on myocardial revascularization
gave Class IA recommendations for both FFR and iFR
to assess the hemodynamic significance of intermediate coronary lesions.10 Resting indices have become
increasingly popular because of more rapid measurement compared with FFR and freedom from adenosine-related costs, symptoms, and heart block. Despite
these advantages, the equivalency in clinical outcomes
with iFR (and by extension, other NHPRs) has been
questioned given the frequent discordance between
FFR and NHPRs.
In this issue of the Journal of the American Heart
Association (JAHA), Lee et al investigated the longterm prognostic implications of NHPRs compared
with FFR on 5-year clinical outcomes of coronary
lesions deferred for revascularization.11 From the
3VFFR-FRIENDS (3-Vessel Fractional Flow Reserve
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for the Assessment of Total Stenosis Burden and
Its Clinical Impact in Patients With Coronary Artery
Disease) registry, the authors analyzed 1024 vessels
from 435 patients who had FFR measured, using offline analysis to derive the various NHPRs at a core
laboratory. Of these 1024 vessels, 160 vessels were
revascularized based primarily on abnormal FFR values. The primary end point was a 5-year vessel-oriented composite outcome measure, defined as a
composite of cardiac death, target vessel-related
myocardial infarction, and ischemia-driven revascularization. The outcomes were compared among
3 groups: revascularized with positive FFR ≤0.80
(n=124), deferred lesions with concurrent negative
NHPR and FFR values (n=688), and deferred vessels
with discordant results (n=57). Among the 3 groups,
the cumulative incidence of vessel-oriented composite outcomes at 5 years was 14.8%, 7.5%, and 14.4%,
respectively for the revascularized, deferred negative
concordant and deferred discordant groups. Despite
a prior study from the same registry12 indicating
nearly numerical equivalence among all of the diastolic NHPRs, the present study surprisingly found
and excluded 74 vessels (7.2%) with NHPR values
that were not consistently classified across the modalities (iFR, resting full-cycle ratio, diastolic pressure
ratio), indicating many of these were in the borderline
range around 0.89.
The results indicate that the prognostic implications
of NHPRs and FFR were similar if the values were
concordant positive (measured as ≤0.89 and ≤0.80
respectively) as both would have classified a lesion as
requiring revascularization. The discriminant function
for 5-year vessel-oriented composite outcomes were
similar among NHPRs and FFR (C-index: 0.623–0.641,
P for comparison=0.215). Deferred lesions with discordant results between NHPRs and FFR demonstrated a
significantly higher risk of 5-year vessel-oriented composite outcomes than those with concordant negative
results but had no excess risk compared with revascularized lesions. This suggests that deferral of revascularization may be a reasonable option for lesions
with discordant results between NHPRs and FFR. The
further implication is that measurement of both NHPR
and FFR would provide better risk stratification of patients than either measurement alone (as one might be
a false positive or negative), though such an inference

ignores the continuous nature of the indices and that
discordance is more likely within the borderline range.
This study provides a relatively large data set
to compare NHPRs and FFR with long-term follow-up.11 Several inherent if minor limitations to this
study are present including (1) nonrandomized design, (2) off-line post hoc calculation of NHPRs, (3)
the revascularization decision was mainly based on
the FFR value, and (4) lack of blinding. More important, the patient population in this study was anatomically and clinically low risk including mostly stable
angina (93.2%) patients with an average SYNTAX
score of 15 in revascularized vessels. This resulted
in low event and revascularization rates, which might
tend to bias toward the null hypothesis that FFR and
NHPRs are equivalent. The results of this study may
not be generalizable to higher risk patients, such
as those with diffuse disease, calcified vessels, or
acute coronary syndrome. Further reducing power
are the small number of patients with discordant results between NHPRs and FFR (n=57, 6.6%), which
is smaller than the 20% seen in several studies including the VERIFY (Verification of Instantaneous
Wave-Free Ratio and Fractional Flow Reserve for the
Assessment of Coronary Artery Stenosis Severity in
Everyday Practice) study.9 This may reflect again the
lower risk cohort of patients studied. Finally, as revascularization decisions were left to the operator, 53
vessels were not revascularized despite concordant
abnormal results in both NHPRs and FFR, and 17
vessels were revascularized despite FFR >0.80, all
of which were excluded from the analysis. This may
pose significant selection bias especially with the low
event rates. As the investigators were not blinded,
there was a possibility that investigators chose not to
revascularize these subsets of patients anticipating a
higher probability of complications with more complex anatomy.
The prognostic importance of discordant results
between FFR and NHPRs in patients with deferred
revascularization is controversial. A post hoc analysis of DEFINE-FLAIR trial showed that in patients
with left anterior descending artery lesions, iFRguided deferral of revascularization had significantly
reduced event rates compared with FFR-guided
deferral.13 Additionally, the results of the combined
DEFINE-FLAIR trial and the iFR-SWEDEHEART trial
revealed more lesions were deferred for revascularization based on iFR as compared with FFR without
increasing the risk of coronary events.14 The difference in prognostic implications between these 2 indices may be because of better agreement of iFR
with coronary flow reserve.15 Individual cases where
coronary flow reserve is normal and high and FFR is
abnormal reflect high flow states in response to adenosine, which pathophysiologically may imply normal
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microvascular function and a benign prognosis. The
study by Lee et al suggests similar safety outcomes
of FFR and all of the diastolic NHPRs in guiding the
deferral of revascularization, extending the results of
DEFINE-FLAIR and iFR-SWEDEHEART to the resting
full-cycle ratio and diastolic pressure ratio.11 Without
measurement error, resting full-cycle ratio and diastolic pressure ratio can be used interchangeably
with iFR for deferral of revascularization, and extending the clinical recommendations of FFR and iFR to
other diastolic NHPRs would be reasonable in daily
clinical practice.
Where does this study leave us? Even if the outcomes are similar between NHPRs and FFR, this study
is unable to distinguish whether NHPR or FFR should
be used for a clinical decision making in cases with
discordant results. The following algorithm could be
considered when evaluating intermediate coronary lesions in the catheterization laboratory.
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1. Start with either FFR or any one of the NHPRs
(preferably iFR as it has prognostic data from
randomized clinical trials, but whatever commercial system you have available). Which to choose
first depends on the availability, local set-up, and
relative contraindication of using adenosine (ie,
chronic obstructive pulmonary disease, asthma,
heart block, caffeine use).
2. Perform second index if:
a the clinical suspicion for symptoms related to the
lesion is high but either FFR or NHPR is negative.
b or the initial measurement is borderline (0.75–0.85
FFR, 0.85–0.93 NHPR).
3. If the second index is negative, defer revascularization (concordant negative).
4. If the second index is positive, (discordant) then you
have the option to defer revascularization, particularly if the risks of revascularization are high (lesions
that are calcified, bifurcation, complex). Performing
intravascular imaging with ultrasound or optical coherence tomography to assess plaque morphology
and percent diameter or minimal lumen area may be
considered both to assess lesion complexity and
provide a third measure of potential significance.
Although this study suggests that simultaneous
measurement of both NHPRs and FFR would provide better risk stratification of patients when revascularization is deferred, this would not be necessary
in all or even most cases. Given the similar safety
outcomes of FFR and NHPRs in guiding the deferral of revascularization, this study supports the use
of NHPR potentially alone. The choice of selecting
1 physiologic index in the case of discordant results remains uncertain and further studies with a
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larger sample and longer-term follow-up are needed.
To date, there remains no safety signal to argue
against using just an NHPR, which will be a relief to
the many operators who prefer a faster and simpler
measurement.
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